Generate Biomedicines, Inc.
GENB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002100782
In the last 90 days, Generate Biomedicines, Inc. insiders filed 0 open-market purchases and 1 sale; 86 institutions reported holding it in 13F filings for Q2 2026, worth $1.69B in total; ARK Invest is the only superinvestor holding it.
Superinvestors holding GENB, Q2 2026
1 superinvestor reports holding Generate Biomedicines, Inc. on Form 13F, worth $21.7M in total. Weight is Generate Biomedicines, Inc.'s share of each 13F portfolio; actions compare shares with Q1 2026.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| ARK InvestCathie Wood | 0.1% | 1,284,617 | $21.7M | Added+157.7% |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of GENB each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2026
1 superinvestor holding at quarter end
- Added
- ARK Invest (+157.7%)
Q1 2026
1 superinvestor holding at quarter end
- New
- ARK Invest